SRRK Q4 2019 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$4B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

-$6M-85.7% margin

Operating Income

-$12M-163.0% margin

Net Income

-$12M-152.8% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+58.6%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$196M

Total Liabilities

$83M

Stockholders' Equity

$113M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	-$6M	-$10M	+35.9%
Operating Income	-$12M	-$16M	+20.6%
Net Income	-$12M	-$15M	+22.7%